We obtained another GEO dataset (GSE4170) [34] and compared the IL8 expression level from 23 chronic phase CML patients to 9 of those patients who were treated with imatinib at the chronic phase and later relapsed. Here, CXCL8 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.